Milestone Scientific (MLSS) Announces Proposed Public Offering of Common Stock

Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it has commenced an underwritten public offering of shares of its common stock (the “Offering”). The Company also expects to grant to the underwriters a 45-day option to purchase up to an additional 15% of the shares of common stock offered in the Offering on the same terms and conditions. All of the shares of common stock are being offered by the Company. The Offering is subject to market and other conditions, and there can be no assurance as to whether or when the Offering may be completed, or as to the actual size or terms of the Offering.

Maxim Group LLC is acting as the sole book-runner for the Offering.

You May Also Be Interested In

• Realty Income closes $1B convertible notes offering
• MicroVision launches public offering of shares and warrants
• Robinhood Ventures Fund II prices IPO at $25 per share on NYSE